Copyright Agreement

Copyright notice and instructions for obtaining electronic and printed copies

• 
  

  Copyright notice

      ● Once an manuscript has been accepted by China Oncology, the the authors will transfer the copyright of the manuscript to the Editorial Department of China Oncology, including but not limited to the rights to digitally reproduce, distribute, and compile the article, and the right to disseminate the article to the public over information networks, and the right to translate the article, and the right to act for domestic and foreign literature retrieval system or database collection shall be transferred to the Editorial Office of China Oncology. The copyright royalties of the article and the journal’s manuscript remuneration shall be made as a one-time payment to the authors.

      ● After publication of the article, the authors shall own the right of signature, the right to maintain the integrity of work, and the right of modification. And the first author shall be the representative copyright owner. Any author wanna use the published article must obey the Creative Commons Attribution-Non Commercial-No Derivatives 4.0 International (CC-BY-NC-ND 4.0) License (more information please visit the following content Instructions for obtaining electronic and printed copies) .

       ● Manuscripts that have passed the final review by the editor-in-chief (or editorial board) and are subsequently revised shall first be uploaded to the China National Knowledge Infrastructure publishing platform (www.cnki.net) for online publication and published on the journal’s website (www.china-oncology.com). If the authors do not consent to the electronic dissemination of the article, a statement must be enclosed with the manuscript submission, otherwise they will be deemed to have agreed to electronic publication.

  Instructions for obtaining electronic and printed copies

      ● China Oncology is an open access journal that operates a single-blind peer-review process. All content in this journal is distributed under a Creative Commons Attribution-Non Commercial-No Derivatives 4.0 International (CC-BY-NC-ND 4.0) License. All articles are published in open access format as defined by the CC-BY-NC-ND 4.0 License. Published articles can be made public immediately and are permanently accessible free of charge on the official website (www.china-oncology.com), allowing users to read, download, copy, print, search, or obtain a link to the full text of the articles, or use them for other legitimate purposes.

  Instructions for free access and use:

  All users of articles in this journal should use the CC-BY-NC-ND 4.0 License as a prerequisite. The License allows users to copy and distribute articles provided that:

        A. This is not done for commercial purposes and further does not permit distribution of the article if it is changed or edited in any way.

        B. The user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.

        C.  No derivatives including remix, transform, or build upon the material was allowed for distribution.

  ● Once a manuscript has been published, the first author is entitled to 2 free printed journals of the current issue.

  ● Libraries, companies, research institutions, readers, etc. who needs printed journals must subscribe, for details please visit:http://www.china-oncology.com/EN/column/column363.shtml) for details.

  
  

  Download the Copyright Transfer Agreement.doc

  
  
  
  

  The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

  
  

2019-10-16 Visited: 127593